Evidence map›Paper›PMID 21205640›Full record

ArticleScience (New York, N.Y.)2011

Induction of colonic regulatory T cells by indigenous Clostridium species.

Koji Atarashi, Takeshi Tanoue, Tatsuichiro Shima, Akemi Imaoka, Tomomi Kuwahara, Yoshika Momose, Genhong Cheng, Sho Yamasaki, Takashi Saito, Yusuke Ohba and 7 more

3 registry-linked trialsAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 2,165 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2,165citing papers in PubMed, 3 pooled it
65.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04046432 nacompletednot on this mapstarted 2017, after this paper: background citation

Effects of Vigiis 101-LAB on Gut Health

TypeinterventionalSponsorSunWay Biotech Co., LTD.Ran2017 to 2018Enrolled54ConditionsGastrointestinal MicrobiomeArmsVigiis 101-LAB, Placebo
NCT04088474 nacompletednot on this mapstarted 2016, after this paper: background citation

Functional Assessment in The Intestinal Flora Improvement

TypeinterventionalSponsorSunWay Biotech Co., LTD.Ran2016 to 2016Enrolled36ConditionsGastrointestinal MicrobiomeArmsVigiis 101-LAB, Placebo
NCT07626606 recruitingnot on this mapstarted 2026, after this paper: background citation

Temporal and Spatial Immune Profiling of Oral Rotavirus Vaccine Responses in Zambian Adults With Environmental Enteropathy

TypeobservationalSponsorCentre for Infectious Disease Research in ZambiaRan2026 to 2026Enrolled43ConditionsFeasibility Study, Vaccine Immune Response, Rota Virus Gastroenteritis, TranscriptomicsArmsRotarix®,
3 · Its place in the literature

Who cites it

2,165 citing papers in PubMed, 3 syntheses or guidelines pooled it, 3,604 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Gut microbes · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Functional Heterogeneity ofMicroorganisms · 2026
    Article
  18. Review
  19. Article
  20. Review

2,105 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Koji AtarashiDepartment of Immunology, Graduate School of Medicine, University of Tokyo, Tokyo 113-0033, Japan.
Takeshi Tanoue
Tatsuichiro Shima
Akemi Imaoka
Tomomi Kuwahara
Yoshika Momose
Genhong Cheng
Sho Yamasaki
Takashi Saito
Yusuke Ohba
Tadatsugu Taniguchi
Kiyoshi Takeda
Shohei Hori
Ivaylo I Ivanov
Yoshinori Umesaki
Kikuji Itoh
Kenya Honda
RIKEN Center for Integrative Medical Sciences · JPThe University of Tokyo · JPYakult Central Institute · JPColumbia University Irving Medical Center · USJapan Science and Technology Agency · JPUniversity of California, Los Angeles · US

Funding

Mechanisms of Biodefense By Toll-Like ReceptorsR01AI056154 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHENG, GENHONG · 2004 to 2014
$3.7M
Role of RIP2 in Biodefense Against Listeria InfectionR01AI052359 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHENG, GENHONG · 2004 to 2008
$1.7M
Regulation of Mucosal Th17 Cell Responses by Intestinal BacteriaR00DK085329 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI IVANOV, IVAYLO IVANOV · 2011 to 2013
$721k
NIAID NIH HHS R01 AI052359NIAID NIH HHS R01 AI056154NIDDK NIH HHS R00 DK085329
6 · The paper itself

Abstract

CD4(+) T regulatory cells (T(regs)), which express the Foxp3 transcription factor, play a critical role in the maintenance of immune homeostasis. Here, we show that in mice, T(regs) were most abundant in the colonic mucosa. The spore-forming component of indigenous intestinal microbiota, particularly clusters IV and XIVa of the genus Clostridium, promoted T(reg) cell accumulation. Colonization of mice by a defined mix of Clostridium strains provided an environment rich in transforming growth factor-β and affected Foxp3(+) T(reg) number and function in the colon. Oral inoculation of Clostridium during the early life of conventionally reared mice resulted in resistance to colitis and systemic immunoglobulin E responses in adult mice, suggesting a new therapeutic approach to autoimmunity and allergy.

Indexed as

AnimalsAnti-Bacterial AgentsCecumCells, CulturedClostridiumColitisColonFecesForkhead Transcription FactorsGerm-Free LifeImmunity, InnateImmunoglobulin EInterleukin-10Intestinal MucosaIntestine, SmallMetagenomeAnti-Bacterial AgentsForkhead Transcription FactorsFoxp3 protein, mouseImmunoglobulin EInterleukin-10Receptors, Pattern RecognitionTransforming Growth Factor beta

Identifiers

PMID21205640
PMCPMC3969237
OpenAlexW2110389012

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.